Skip to main content
Figure 1 | BMC Pharmacology and Toxicology

Figure 1

From: Validation of a transparent decision model to rate drug interactions

Figure 1

Visualisation of proposed action-oriented decision model to rate drug-drug interactions. The six question sets relate to: AIA (apparent interaction), SAE (serious adverse event), ACT (action), SUR (surveillance), ATE (alternative), RBR (risk-benefit ratio). Five possible ratings are DM: A (no action required), DM: B (precautionary measures), DM: C (clinical monitoring), DM: D (avoid) and DM: E (contraindicated).

Back to article page